Cardiac glycosides are potent inhibitors of interferon-β gene expression

Nature Chemical Biology

Volumn 7, Issue 1, 2011, Pages 25-33

  Ye, Junqiang ^a   Chen, Shuibing ^b   Maniatis, Tom ^a,c  

^a HARVARD UNIVERSITY   (United States)

^b Harvard University   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA INTERFERON; BUFALIN; CARDIAC GLYCOSIDE; DOUBLE STRANDED DNA; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; PROTEIN; RIG 1 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSOR; SIGNAL TRANSDUCTION; VIRUS INDUCTION;

EID: 78650510234     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.476     Document Type: Article

References (48)

1. Sen, G.C. Viruses and interferons. Annu. Rev. Microbiol. 55, 255-281 (2001).
2. Honda, K., Takaoka, A. & Taniguchi, T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349-360 (2006). (Pubitemid 44354220)
3. Chiu, Y.H., Macmillan, J.B. & Chen, Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576-591 (2009).
4. Ablasser, A. et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10, 1065-1072 (2009).
5. García-Sastre, A. & Biron, C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312, 879-882 (2006). (Pubitemid 43727313)
6. Le Bon, A. & Tough, D.F. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14, 432-436 (2002). (Pubitemid 34671244)
7. Banchereau, J. & Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25, 383-392 (2006). (Pubitemid 44354221)
8. Hall, J.C. & Rosen, A. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat. Rev. Rheumatol. 6, 40-49 (2010).
9. Mandl, J.N. et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat. Med. 14, 1077-1087 (2008).
10. Whittemore, L.A. & Maniatis, T. Postinduction turnoff of beta-interferon gene expression. Mol. Cell. Biol. 10, 1329-1337 (1990). (Pubitemid 20105001)
11. Jacquelin, B. et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119, 3544-3555 (2009).
12. Maniatis, T. et al. Structure and function of the interferon-beta enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63, 609-620 (1998).
13. Sun, L., Liu, S. & Chen, Z.J. SnapShot: pathways of antiviral innate immunity. Cell 140, 436-436.e2 (2010).
14. Ford, E. & Thanos, D. The transcriptional code of human IFN-beta gene expression. Biochim. Biophys. Acta 1799, 328-336 (2010).
15. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006). (Pubitemid 43827959)
16. Cui, S. et al. The C-terminal regulatory domain is the RNA 5?-triphosphate sensor of RIG-I. Mol. Cell 29, 169-179 (2008). (Pubitemid 351172822)
17. Takahasi, K. et al. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29, 428-440 (2008).
18. Seth, R.B., Sun, L., Ea, C.K. & Chen, Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669-682 (2005). (Pubitemid 41242633)
19. Tang, E.D. & Wang, C.Y. MAVS self-association mediates antiviral innate immune signaling. J. Virol. 83, 3420-3428 (2009).
20. Fujita, T. A nonself RNA pattern: tri-p to panhandle. Immunity 31, 4-5 (2009).
21. Myong, S. et al. Cytosolic viral sensor RIG-I is a 5?-triphosphate- dependent translocase on double-stranded RNA. Science 323, 1070-1074 (2009).
22. Gack, M.U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007).
23. Gack, M.U., Nistal-Villan, E., Inn, K.S., Garcia-Sastre, A. & Jung, J.U. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J. Virol. 84, 3220-3229 (2010).
24. Saha, S.K. et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25, 3257-3263 (2006).
25. Guo, B. & Cheng, G. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282, 11817-11826 (2007). (Pubitemid 47100710)
26. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988 (2005). (Pubitemid 41486182)
27. Ishikawa, H. & Barber, G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674-678 (2008).
28. Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538-550 (2008).
29. Schröder, M., Baran, M. & Bowie, A.G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 27, 2147-2157 (2008).
30. Prassas, I. & Diamandis, E.P. Novel therapeutic applications of cardiac glycosides. Nat. Rev. Drug Discov. 7, 926-935 (2008).
31. Hemmi, H. et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199, 1641-1650 (2004). (Pubitemid 38821997)
32. Fitzgerald, K.A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 (2003).
33. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004). (Pubitemid 39023305)
34. Saito, T. et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. USA 104, 582-587 (2007). (Pubitemid 46123068)
35. Langer, G.A. Ionic basis of myocardial contractility. Annu. Rev. Med. 28, 13-20 (1977).
36. Lingrel, J.B. The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase. Annu. Rev. Physiol. 72, 395-412 (2010).
37. Ohtsubo, M., Noguchi, S., Takeda, K., Morohashi, M. & Kawamura, M. Site-directed mutagenesis of Asp-376, the catalytic phosphorylation site, and Lys-507, the putative ATP-binding site, of the alpha-subunit of Torpedo californica Na+/K(+)-ATPase. Biochim. Biophys. Acta 1021, 157-160 (1990). (Pubitemid 20037564)
38. Simpson, C.D. et al. Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation. Cancer Res. 69, 2739-2747 (2009).
39. Izquierdo, I. Nimodipine and the recovery of memory. Trends Pharmacol. Sci. 11, 309-310 (1990). (Pubitemid 20240656)
40. Trube, G., Rorsman, P. & Ohno-Shosaku, T. Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pflugers Arch. 407, 493-499 (1986). (Pubitemid 17175041)
41. Garvin, J.L., Simon, S.A., Cragoe, E.J. Jr. & Mandel, L.J. Phenamil: an irreversible inhibitor of sodium channels in the toad urinary bladder. J. Membr. Biol. 87, 45-54 (1985). (Pubitemid 15236751)
42. Xie, Z. & Cai, T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 3, 157-168 (2003).
43. Gee, P. et al. Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity. J. Biol. Chem. 283, 9488-9496 (2008).
44. Cyert, M.S. Regulation of nuclear localization during signaling. J. Biol. Chem. 276, 20805-20808 (2001). (Pubitemid 37413055)
45. Yang, Q. et al. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc. Natl. Acad. Sci. USA 102, 9631-9636 (2005). (Pubitemid 40981732)
46. Ronnblom, L. & Elkon, K.B. Cytokines as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6, 339-347 (2010).
47. Meng, Z. et al. Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer 115, 5309-5318 (2009).
48. Chen, S. et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 5, 258-265 (2009)